Status:
NOT_YET_RECRUITING
Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.
Lead Sponsor:
Aswan University
Conditions:
Cesarean Section Complications
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.
Detailed Description
This an interventional study comparing effect of Standard dose of Hyperbaric bupivacaine with 20% reduction of dose of Hyperbaric Bupivacaine in Elective Cesarean Delivery. First, we determaine if th...
Eligibility Criteria
Inclusion
- • Pregnant women aged 18-45 years.
- ASA physical status II-III.
Exclusion
- • Twin pregnancies.
- Contraindications to spinal anesthesia (e.g., coagulopathy, infection).
- Patients with incomplete preoperative data for risk stratification.
Key Trial Info
Start Date :
September 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2026
Estimated Enrollment :
333 Patients enrolled
Trial Details
Trial ID
NCT07140640
Start Date
September 15 2025
End Date
March 30 2026
Last Update
August 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aswan university
Aswān, Aswan Governorate, Egypt, 000